A Blueprint for Breakthroughs
<p>DeSci is ripping up the <a href="https://www.nature.com/articles/s41587-023-02119-6" rel="noopener ugc nofollow" target="_blank"><em>rulebook for bio</em></a>. By throwing open the doors to scientific knowledge and harnessing the power of open-source, it’s unleashing a tidal wave of credible new approaches and collaborations. The result? A total disruption of the typical go-to-market model for the drug development and biotech industry.</p>
<p><strong>The problem: </strong>Pharma’s ROI on R&D is in freefall. Skyrocketing costs, snail-pace development, and sky-high abandonment rates, leaving many potential breakthroughs unrealised.</p>
<p><a href="https://medium.com/id-theory/a-blueprint-for-breakthroughs-6a0818478acb"><strong>Read More</strong></a></p>